Aciont Inc. Press releases
May 09, 2013
The National Eye Institute awarded a $2.03 million phase IIB grant to Aciont Inc. to fund the clinical development of a non-invasive, passive diffusion-based treatment for uveitis (referred to as DSP-Visulex-TM).
Apr 16, 2013
Aciont To Present at ARVO 2013 Annual Meeting Salt Lake City, UT – April 15, 2013 – Aciont Inc. announced today that Dr. Sarah A. Molokhia and Dr.